"Executive Summary:  The global hypolipidemic drugs market size was valued at USD 20.76 billion in 2024 and is projected to reach USD 26.40 billion by 2032, with a CAGR of 3.05% during the forecast period of 2025 to 2032.   The global Hypolipidemic Drugs Market is witnessing dynamic growth as industries adapt to changing consumer behaviors, technological advancements,...